DM
Dogan, Mutlu
4 yayın · 81 atıf · 2021–2025
Yayın
4
Atıf
81
Yıllar
3
Yayınlar
| Başlık | Yıl | Tip | Atıf |
|---|---|---|---|
|
"Pre-Treatment" and "Post-Treatment" Systemic Inflammatory Markers: Is There Any Prognostic Role for Metastatic Cervical Cancer on Bevacizumab Containing Treatment?
|
2025 | Article | 2 |
|
Locoregional Treatment Improves Survival in De Novo Bone-only Metastatic Breast Cancer: Long-term Results of the Prospective, Multi-institutional Study - Protocol BOMET MF14-01
|
2023 | Meeting Abstract | 0 |
|
Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience
|
2021 | Article | 9 |
|
The Effect of Primary Surgery in Patients with De Novo Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multi-Center, Prospective Registry Study
|
2021 | Article | 70 |